Sinopharm

China’s habit of disappearing and censoring critics is not the way to win trust in its vaccine industry.

The report from Caixin comes as the efficacy of homegrown vaccines from Sinopharm and Sinovac continue to be questioned.

Struggling to contain an outbreak of COVID-19, Vietnam's communist government swallows its pride.

Despite some concerns and criticisms abroad, most Chinese (and expats) are eager to roll up their sleeves for the jab.

For myriad reasons, vaccination programs in Central Asia are proceeding slowly. Hesitancy is one factor.

China's vaccine makers are looking at ways to increase the efficiency of their shots.

China’s latest disclosure could reconfigure regional politics and promote domestic development across the Americas.

The gifted 150,000 doses will be enough for 75,000 people to be vaccinated. While it’s a start, Kyrgyzstan’s population exceeds 6.4 million.

An in-depth look at where China's vaccines are going hints at the motivations behind the campaign.

Despite cooperating on some aspects, China and Russia are also directly competing for the same vaccine markets - and the national prestige that comes with it.

The government’s mass vaccination start date is in flux, and Filipinos still harbor fears after a 2016 dengue vaccine scandal eroded public confidence in vaccinations.